Periscope Capital’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Periscope Capital’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,465	Closed	-$3.17M	–	379
2020 Q3	$3.17M	Sell	14,465 -1,960	-12%	-$422K	0.22%	155
2020 Q2	$3.53M	Sell	16,425 -15	-0.1%	-$3.19K	0.32%	112
2020 Q1	$3.47M	Buy	16,440 +1,850	+13%	+$388K	0.42%	103
2019 Q4	$3.06M	Hold	14,590	–	–	0.37%	112
2019 Q3	$3.02M	Sell	14,590 -10	-0.1%	-$2.06K	0.39%	102
2019 Q2	$3M	Buy	14,600 +2,515	+21%	+$512K	0.43%	93
2019 Q1	$2.43M	Hold	12,085	–	–	0.42%	90
2018 Q4	$2.38M	Buy	+12,085	New	+$2.37M	0.44%	81

Other funds holding RVPH

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Periscope Capital's RVPH Position: Q4 2020 in Review

Periscope Capital sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 14,465 shares — an estimated $3.17M sold.

Periscope Capital first reported a position in RVPH in Q4 2018 and held it in 8 quarters. The position peaked at $3.53M in Q2 2020. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

Periscope Capital reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
Periscope Capital sold 14,465 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $3.17M.
Periscope Capital first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 8 quarters.
Periscope Capital's REVIVA PHARMA HLDGS INC position peaked at $3.53M in Q2 2020.
3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Periscope Capital's 13F filing for Q4 2020, filed 10 Feb 2021.